← Back to Clinical Trials
Recruiting NCT06690788

NCT06690788 PreventT2 Together: Examining the Efficacy of Couple-based Lifestyle Intervention to Prevent Type 2 Diabetes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06690788
Status Recruiting
Phase
Sponsor University of Utah
Condition Prediabetic State
Study Type INTERVENTIONAL
Enrollment 324 participants
Start Date 2025-03-06
Primary Completion 2028-11

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Individual intervention condition (PreventT2)Couple-based intervention condition (PreventT2 Together; couple-based adaptation of 2021 PreventT2; approved by the CDC in November 2022 as an Alternate Curriculum for use in the NDPP)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 324 participants in total. It began in 2025-03-06 with a primary completion date of 2028-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Nearly half of adults in the United States have or are at risk of developing type 2 diabetes. The overall goal of this community-engaged research is to examine the efficacy of an innovative couple-based lifestyle intervention to prevent type 2 diabetes that is applicable to a broad range of partnered adults in the United States. By simultaneously targeting lifestyle and perceived support from romantic partners, there is a high likelihood of creating lasting changes in both

Eligibility Criteria

Inclusion Criteria: 1. "Target partner" is eligible for the National DPP per CDC eligibility requirements: * BMI ≥ 25 kg/m² (≥ 23 kg/m² if Asian American), and * Do not have a diagnosis of type 1 or type 2 diabetes, and * Not currently pregnant, and * High risk for type 2 diabetes based on: (i) CDC Prediabetes Risk Test score ≥ 5, (ii) clinically diagnosed Gestational Diabetes during a previous pregnancy (for women), or (iii) a blood test result indicative of prediabetes in the past year (i.e., fasting blood glucose 100-125 mg/dl; plasma glucose 140-199 mg/dl measured 2 hours after a 75 g glucose load; or HbA1c 5.7%-6.4%). 2. The couple has lived together for 1+ years. 3. Both partners are willing to participate in the research. 4. Both partners are at least 18 years old. 5. Both partners are fluent in English. EXCLUSION CRITERIA: 1. "Supporting partner" has a diagnosis of Type 2 Diabetes. 2. Either partner: * Has a diagnosis of another chronic disease (unless no major events/changes for 3+ months), or * Is currently on medication or engaged in lifestyle intervention for prediabetes or obesity, or * Has previously participated in the National DPP, or * Reports discomfort participating in a lifestyle program with their partner, or * Reports a low level of relationship commitment (i.e., "4" or lower on a scale from 1 (do not agree at all) to 7 (agree completely) on the item "I want this relationship to stay strong no matter what rough times we encounter."; Owen et al., 2011).

Contact & Investigator

Central Contact

Elizabeth Z Beaulieu, B.S.

✉ elizabeth.beaulieu@psych.utah.edu

📞 801-696-3757

Principal Investigator

Katherine JW Baucom, PhD

PRINCIPAL INVESTIGATOR

University of Utah

Frequently Asked Questions

Who can join the NCT06690788 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Prediabetic State. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06690788 currently recruiting?

Yes, NCT06690788 is actively recruiting participants. Contact the research team at elizabeth.beaulieu@psych.utah.edu for enrollment information.

Where is the NCT06690788 trial being conducted?

This trial is being conducted at Salt Lake City, United States.

Who is sponsoring the NCT06690788 clinical trial?

NCT06690788 is sponsored by University of Utah. The principal investigator is Katherine JW Baucom, PhD at University of Utah. The trial plans to enroll 324 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology